News
3d
News Medical on MSNVanderbilt and Parse Biosciences team up to develop antibody treatments for measlesVanderbilt University Medical Center and Parse Biosciences, an innovator in single-cell sequencing, are collaborating on a ...
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of the Parse GigaLab™ to scale single cell ...
Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced a groundbreaking study published in the journal Science that utilized Parse’s ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA ...
INTEGRA Biosciences and Parse Biosciences have partnered to automate single cell RNA sequencing (scRNA-seq) on the ASSIST PLUS pipetting robot. This new protocol combines Parse Biosciences ...
SEATTLE, November 21, 2024--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that OMAPiX has been ...
(BUSINESS WIRE )--Parse Biosciences , a leading provider of accessible and scalable single cell sequencing solutions, today announced the. Tuesday, 02 January 2024 12:17 GMT.
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that OMAPiX has been certified as the latest member of its Certified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results